Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02561806
What this trial is testing

Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 302
Large-scale testing (Phase 3)Ended earlyNCT00833053
What this trial is testing

Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 39
Large-scale testing (Phase 3)Study completedNCT04785326
What this trial is testing

Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Dong-A ST Co., Ltd. 598
Not applicableStudy completedNCT02305953
What this trial is testing

Cytokines and Vascular Inflammation in Psoriasis

Who this might be right for
Vascular InflammationPsoriasisCoronary Atherosclerosis
Innovaderm Research Inc. 96
Post-approval studies (Phase 4)Study completedNCT03739853
What this trial is testing

Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial

Who this might be right for
Psoriatic Arthritis
University of Oxford 192
Large-scale testing (Phase 3)UnknownNCT05249972
What this trial is testing

A Phase III Study in Subjects With Mild to Moderate Psoriasis.

Who this might be right for
Mild to Moderate Psoriasis
Lipidor AB 294
Not applicableEnded earlyNCT07449234
What this trial is testing

Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag Ltd. 9
Post-approval studies (Phase 4)UnknownNCT01088165
What this trial is testing

The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis

Who this might be right for
PsoriasisCardiovascular DiseasesDiabetes Mellitus, Type 2
Medical University of Vienna 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT06875934
What this trial is testing

A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Guangdong Hengrui Pharmaceutical Co., Ltd 145
Testing effectiveness (Phase 2)UnknownNCT05604898
What this trial is testing

Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 139
Testing effectiveness (Phase 2)Looking for participantsNCT06231381
What this trial is testing

Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)

Who this might be right for
Generalized Pustular Psoriasis (GPP)
Shanghai Huaota Biopharmaceutical Co., Ltd. 33
Early research (Phase 1)WithdrawnNCT01260844
What this trial is testing

Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.

Who this might be right for
Moderate to Severe Plaque Psoriasis
Abbott 12
Large-scale testing (Phase 3)Study completedNCT06588738
What this trial is testing

A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001

Who this might be right for
Plaque Psoriasis
Alumis Inc 862
Post-approval studies (Phase 4)Study completedNCT00336973
What this trial is testing

Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent

Who this might be right for
Psoriasis
Genentech, Inc. 73
Testing effectiveness (Phase 2)Study completedNCT02931838
What this trial is testing

Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 268
Large-scale testing (Phase 3)Looking for participantsNCT07265284
What this trial is testing

Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. 104
Testing effectiveness (Phase 2)Study completedNCT03010527
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 217
Early research (Phase 1)Study completedNCT02156466
What this trial is testing

Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis Subjects

Who this might be right for
Psoriasis
Merck KGaA, Darmstadt, Germany 41
Not applicableStudy completedNCT00678470
What this trial is testing

Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Psoriasis
University of California, San Francisco 18
Early research (Phase 1)Ended earlyNCT01948271
What this trial is testing

Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 3
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation